Hyperfine Inc., a leader in health technology, announced that it has received FDA clearance for its new generation Swoop® system, an AI-powered portable MRI specifically designed for brain imaging. This latest approval represents a significant technological advancement for the company, featuring a completely redesigned portable MRI scanner integrated with the proprietary Optive AI™ software. This new system promises enhanced image quality, functionality, and usability, marking a transformative shift in brain imaging for clinicians and patients across various healthcare settings. Hyperfine plans to introduce this system in hospitals and clinics throughout the United States, aiming to make high-quality brain imaging more accessible and efficient.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。